MgB6 PRO 450
MGB6 PRO 450 (IMPROVES YOUR HEALTH AND PHYSICAL PERFORMANCE) MgB6 PRO 450 consists on Magnesium Bisglycinate which is the highest bioavailability form of magnesium that exists today. It is made from high quality magnesium and two glycine molecules.
Magnesium offers a lot of health benefits. Some studies have revealed that a low concentration of magnesium can negatively affect physical performance. Supplementation of a bioavailable form of magnesium, such as MgB6 PRO 450, helps to reduce fatigue and cramps and improves mental status. A better mental state is the result of the impact of magnesium on the nervous and endocrine systems.
Magnesium also affects electrolyte balance and bone mineral density.
Benefits of magnesium:
- Anti-stress effect
- Strengthening of bones and teeth
- Kidney Care
- Menstrual pains
- Relieves Constipation
- Prevents cardiovascular diseases
- Good digestions
- Muscle Relaxation
- Reduces blood pressure
- Prevents premature births
- Maintains body pH
- Against Insomnia
Recommended Use: As a dietary supplement take 1 capsule daily, preferably with a meal or as directed by the nutritionist.
Ingredients per capsule: Magnesium bisglycinate (20% Mg) 450 mg, Vitamin B6 (pyridoxine hydrochloride), Coating agent (gelatin), Charging agent (calcium phosphate), Anti-caking agents (magnesium stearate, magnesium dioxide)
DATASHEET: MGB6 PRO 90 CAP
LEGAL NOTE: Products reviewed here are food supplements or as established by European Directive 2002/46/EC on food supplements and all can be legally sold in all countries of the European Community, under Articles 28, 29 and 30 of the treaty the European Community and by Articles 1 to 4 of the European Parliament Decision 3052/95/EC number. Dietary supplements are not trying to replace a balanced and varied diet, are presented only in order to supplement the intake of nutrients of a normal diet. Neither treat, prevent, diagnose or cure any disease, acts attributable to drugs, as defined by European Directive 2004/27/EC of 31 March, the Council and European Parliament on medicinal products.